Behind the EpiPen Pricing Scandal: Why Generics Don’t Necessarily Reduce Prices – Mish Proposals


Despite widespread availability of generic versions, customers do not often use them. Why?

In some cases, pharmacies are under obligation to not mention cheaper alternatives. Some pharmacists may not be aware of cheaper alternatives because they do not know what a plan covers.

And behind the scenes, there is the complex role of middleman pharmacy-benefit managers (PBMs), who take a cut out of sales and collude with drug makers to keep prices high.

View original post 1,588 more words


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s